Differential Immunogenicity of Vaccinia and HIV-1 Components of a Human Recombinant Vaccine in Mucosal and Blood Compartments

Vaccine - Netherlands
doi 10.1016/j.vaccine.2008.05.084
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Retrovirology
VirologyInfectious Diseases
2012English

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2020English

Immunogenicity of Recombinant Modified Vaccinia Ankara Following a Single or Multi-Dose Vaccine Regimen in Rhesus Monkeys

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2009English

Immunogenicity and Efficacy of Recombinant RSV-F Vaccine in a Mouse Model

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

Immunogenicity of Nonreplicating Recombinant Vaccinia Expressing HLA-A201 Targeted or Complete MART-1/Melan-A Antigen

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2001English

Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 Gag Gene

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy